Ken Griffin’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.4M | Buy |
1,477,675
+1,344,608
| +1,010% | +$49.5M | 0.01% | 496 |
|
|
2025
Q1 | $4.71M | Sell |
133,067
-3,997
| -3% | -$141K | ﹤0.01% | 1812 |
|
|
2024
Q4 | $6M | Sell |
137,064
-143,873
| -51% | -$6.29M | ﹤0.01% | 1660 |
|
|
2024
Q3 | $12.7M | Sell |
280,937
-127,905
| -31% | -$5.8M | ﹤0.01% | 1101 |
|
|
2024
Q2 | $15.9M | Sell |
408,842
-179,246
| -30% | -$6.96M | ﹤0.01% | 979 |
|
|
2024
Q1 | $19M | Sell |
588,088
-315,941
| -35% | -$10.2M | ﹤0.01% | 912 |
|
|
2023
Q4 | $25.9M | Buy |
904,029
+657,571
| +267% | +$18.9M | 0.01% | 743 |
|
|
2023
Q3 | $6.82M | Buy |
+246,458
| New | +$6.82M | ﹤0.01% | 1408 |
|
|
2023
Q2 | – | Sell |
-323
| Closed | -$7K | – | 6385 |
|
|
2023
Q1 | $7K | Sell |
323
-176,416
| -100% | -$3.82M | ﹤0.01% | 5579 |
|
|
2022
Q4 | $4.21M | Buy |
176,739
+152,687
| +635% | +$3.64M | ﹤0.01% | 1932 |
|
|
2022
Q3 | $474K | Sell |
24,052
-173,008
| -88% | -$3.41M | ﹤0.01% | 4131 |
|
|
2022
Q2 | $3.84M | Buy |
197,060
+130,258
| +195% | +$2.54M | ﹤0.01% | 2117 |
|
|
2022
Q1 | $1.7M | Sell |
66,802
-297,103
| -82% | -$7.58M | ﹤0.01% | 3190 |
|
|
2021
Q4 | $9.16M | Buy |
363,905
+270,483
| +290% | +$6.81M | ﹤0.01% | 1535 |
|
|
2021
Q3 | $2.57M | Sell |
93,422
-104,339
| -53% | -$2.87M | ﹤0.01% | 2730 |
|
|
2021
Q2 | $6.28M | Sell |
197,761
-919,431
| -82% | -$29.2M | ﹤0.01% | 1895 |
|
|
2021
Q1 | $51.3M | Sell |
1,117,192
-122,484
| -10% | -$5.62M | 0.01% | 455 |
|
|
2020
Q4 | $49.1M | Buy |
1,239,676
+865,211
| +231% | +$34.3M | 0.01% | 431 |
|
|
2020
Q3 | $13M | Sell |
374,465
-47,471
| -11% | -$1.65M | ﹤0.01% | 968 |
|
|
2020
Q2 | $13.3M | Buy |
421,936
+73,294
| +21% | +$2.31M | ﹤0.01% | 939 |
|
|
2020
Q1 | $7.64M | Buy |
+348,642
| New | +$7.64M | ﹤0.01% | 1172 |
|